Table 1 Estimation of endogenous anti-oxidant capacity in brain tissue of the experimental groups
Groups | Treatment | DOSE | GSH (μg/mg of brain tissue) | SOD (μg/mg of brain tissue) | CAT (μg/mg of brain tissue) |
|---|---|---|---|---|---|
I | Normal control | N/A | 80.67 ± 0.866 | 24.193 ± 0.6776 | 21.92 ± 0.487 |
II | Disease control (HPD) | 1 mg/kg | 55.624 ± 1.774 | 16.4716 ± 0.649 | 3.0733 ± 0.214 |
III | Standard control (STD) | 100 mg/kg | 79.944 ± 1.772*** | 22.88 ± 0.407*** | 13.0083 ± 0.722*** |
IV | Treatment control (ALE 100) | 100 mg./ kg | 71.29 ± 2.33 *** | 21.513 ± 0.574** | 11.612 ± 0.485*** |
V | Treatment control (ALE 200) | 200 mg/ kg | 77.984 ± 1.098*** | 22.234 ± 0.627** | 16.1416 ± 0.593*** |
VI | Treatment control (ALE 300) | 300 mg/kg | 78.577 ± 1.546*** | 23.197 ± 0.6389*** | 19.55 ± 1.209*** |